Author: NCV Newswire

Aurora Cannabis to License CannaRoyalty Cannabis Delivery IP

Aurora Cannabis and CannaRoyalty Sign Letter of Intent for International Drug Delivery Technology Agreement Agreement Covers Award-Winning MüV Specialty Medical Products Line VANCOUVER and OTTAWA, Dec. 13, 2017 /CNW/...
- December 13th, 2017 at 7:36 am

Surna Raises $1.8 Million in Private Placement Equity Sale

Surna Completes $1.8 Million Equity Offering Proceeds to be used for working capital and growth initiatives BOULDER, Colo., Dec. 13, 2017 /PRNewswire/ — Surna Inc. (the “Company”) (OTCQB: SRNA),...
- December 13th, 2017 at 7:16 am

ABCann Acquires Medical Cannabis Clinic for C$3 Million

ABcann Enters into Agreement to Acquire Leading Medical Cannabis Clinic NAPANEE, Ontario and CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV:ABCN) (“ABcann” or the “Company”)...
- December 12th, 2017 at 7:46 am

GW Pharma Closes $317.4 Million Equity Offering

GW Pharmaceuticals plc Announces the Closing of Public Offering of ADSs Raising Gross Proceeds of $317.4 Million and Full Exercise of Underwriter’s Option to Purchase Additional ADSs LONDON, UK,...
- December 12th, 2017 at 6:37 am

DOJA Cannabis Permitted to Import Seeds

DOJA Cannabis Receives Import Permit KELOWNA, BC, Dec. 11, 2017 /CNW/ – DOJA Cannabis Company Limited (“DOJA” or the “Company”) (CSE:DOJA) announced today that its wholly-owned subsidiary has received...
- December 11th, 2017 at 7:55 am

DOJA Cannabis to Raise $15 Million

DOJA Cannabis Announces $15 Million Bought Deal Private Placement of Convertible Debenture Units KELOWNA, BC, Dec. 7, 2017 /CNW/ – DOJA Cannabis Company Limited (“DOJA” or the “Company”) (CSE:DOJA)...
- December 7th, 2017 at 8:12 am

Delta 9 to Raise $20 Million Selling Units at $2.70

Delta 9 Announces C$20.0 Million Bought Deal   WINNIPEG, Dec. 7, 2017 /CNW/ – DELTA 9 CANNABIS INC. (TSXV: NINE) (“Delta 9” or the “Company”) is pleased to announce...
- December 7th, 2017 at 8:02 am

GW Pharma to Raise up to $258.75 Million in Underwritten Deal

GW Pharmaceuticals Announces Proposed Public Offering of ADSs LONDON, Dec. 05, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPRF) (Nasdaq:GWPH) (“GW” or the “Company”), a biopharmaceutical company focused on...
- December 5th, 2017 at 4:38 pm